Zepp Health (NYSE:ZEPP) Downgraded to Sell Rating by Wall Street Zen

Key Points

• Wall Street Zen downgraded Zepp Health from “Hold” to “Sell,” while Fundamental Research maintained a “Buy” rating with a $53.01 price target. MarketBeat lists the overall consensus as “Hold.”
• Zepp Health shares opened at $5.20 and were trading down 3%, with a market capitalization of approximately $76.3 million and a 52-week range of $3.85 to $61.85.
• Insiders own 36% of the company, while hedge funds and institutional investors own 52.61%; CFO Cheng Deng recently sold shares to cover tax withholding obligations tied to vested equity awards.

Zepp Health (NYSE:ZEPP - Get Free Report) was downgraded by investment analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued on Sunday.

Separately, Fundamental Research set a $53.01 price target on shares of Zepp Health and gave the stock a "buy" rating in a report on Tuesday, August 11th. One investment analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $53.01.

Zepp Health Trading Down 3.0%

ZEPP stock opened at $5.20 on Friday. Zepp Health has a 52 week low of $3.85 and a 52 week high of $61.85. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.67 and a current ratio of 0.88. The company's 50-day simple moving average is $5.05 and its 200 day simple moving average is $11.33. The company has a market capitalization of $76.34 million, a PE ratio of -2.06 and a beta of 1.86.

Insiders Place Their Bets

In other Zepp Health news, CFO Cheng Deng sold 9,836 shares of the firm's stock in a transaction dated Friday, June 26th. The stock was sold at an average price of $4.61, for a total value of $45,343.96. Following the sale, the chief financial officer owned 114,539 shares of the company's stock, valued at $528,024.79. This trade represents a 7.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Zepp Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. FIL Ltd bought a new stake in Zepp Health during the fourth quarter valued at approximately $16,858,000. Millennium Management LLC raised its position in shares of Zepp Health by 49.1% during the 4th quarter. Millennium Management LLC now owns 366,826 shares of the company's stock valued at $9,882,000 after buying an additional 120,750 shares in the last quarter. Price T Rowe Associates Inc. MD raised its position in shares of Zepp Health by 17.8% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 295,967 shares of the company's stock valued at $7,974,000 after buying an additional 44,619 shares in the last quarter. Balyasny Asset Management L.P. lifted its holdings in shares of Zepp Health by 46.9% during the 4th quarter. Balyasny Asset Management L.P. now owns 202,775 shares of the company's stock worth $5,463,000 after acquiring an additional 64,692 shares during the last quarter. Finally, UBS Group AG lifted its holdings in shares of Zepp Health by 16,412.0% during the 3rd quarter. UBS Group AG now owns 181,302 shares of the company's stock worth $8,300,000 after acquiring an additional 180,204 shares during the last quarter. 52.61% of the stock is owned by hedge funds and other institutional investors.

Zepp Health Company Profile

Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health's integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.

At the core of Zepp Health's offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source